GE Healthcare has received FDA approval and is releasing to market its new SPECT (single-photon emission computed tomography) system, the Discovery NM 630. The company is touting the potential for lower radiation doses and shorter exam times, while being able to handle patients up to a quarter of a ton thanks to its sturdy table and a 70 cm bore.
A step forward in detector design, the Elite NXT detector enables exceptional image quality. Elite NXT detectors are designed to offer outstanding SPECT resolution and exceptional contrast for superb image quality, all to help clinicians diagnose patients earlier and more accurately. Ultra-thin design and auto-body contouring minimize the distance between the patient and the detectors for excellent resolution while SPECT-optimized collimators and the exceptionally high count rate enable extremely precise event detection.
Innovative and advanced Evolution technology changes the relationship between time, dosage and image quality by allowing clinicians to reduce time or injected patient dose by up to 50 percent in most scanning procedures while maintaining excellent image quality.
Discovery NM 630 ignites streamlined workflow by offering half-time imaging† and fast and flexible robotic gantry motions to enable a whole body and SPECT bone protocol in 15 minutes.
The Discovery NM630 can be upgraded on location to a Discovery NM/CT 670 by adding CT capabilities that can expand services to true hybrid imaging, helping to protect clinicians’ investment through the ability to expand diagnostic horizons as the practice requires and the care mission demands.